Equities
Health CareMedical Equipment and Services
  • Price (USD)26.29
  • Today's Change-0.61 / -2.27%
  • Shares traded4.54m
  • 1 Year change-25.29%
  • Beta1.0083
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.

  • Revenue in USD (TTM)3.90bn
  • Net income in USD-185.00m
  • Incorporated1983
  • Employees15.00k
  • Location
    DENTSPLY SIRONA IncSuite 60W, 221 West Philadelphia StreetYORK 28277-3607United StatesUSA
  • Phone+1 (717) 845-7511
  • Fax+1 (302) 636-5454
  • Websitehttps://www.dentsplysirona.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Envista Holdings Corp2.53bn-1.32bn3.27bn12.80k--1.10--1.29-7.70-7.7014.6417.320.42074.086.37197,937.50-21.981.94-26.292.3454.8957.65-52.255.291.903.920.33570.00-0.1012-2.04-142.10---4.22--
Axonics Inc408.81m-1.71m3.53bn797.00--5.48325.708.65-0.0291-0.02918.1112.610.58561.127.81512,934.80-0.2451-12.67-0.2618-13.7675.8970.04-0.4185-29.687.11--0.00--33.86249.0689.80--23.65--
Evolent Health Inc2.35bn-106.20m3.61bn4.70k--3.38235.801.53-0.9367-0.936720.7110.790.9191--6.55500,823.00-2.91-9.60-3.63-12.5918.5724.50-3.16-13.66---0.23820.326--45.2625.65-660.71---6.18--
Neogen Corp924.22m-9.42m3.78bn2.92k--1.2035.264.09-0.0435-0.04354.2714.510.2032.855.67316,839.90-0.2071.38-0.2141.4450.1948.23-1.024.312.591.190.22080.0012.3717.4158.81--50.02--
Haemonetics Corporation1.33bn114.89m3.83bn3.66k33.524.2317.552.872.232.2325.9217.700.59241.877.05364,751.205.105.025.746.0753.5851.748.618.112.3360.200.57470.0012.016.231.8716.40-11.04--
ICU Medical Inc2.30bn-70.79m4.32bn14.00k--2.1227.531.87-2.92-2.9294.9083.430.52672.1314.68164,591.20-1.621.46-1.831.6532.4734.11-3.072.231.080.55550.44120.00-0.915410.0460.08---1.45--
Integer Holdings Corp1.67bn105.37m4.34bn10.50k42.432.7920.742.603.053.0548.2746.340.55744.885.10158,938.203.523.283.783.5326.7726.946.316.401.963.670.42150.0016.035.6238.719.3321.71--
Procept Biorobotics Corp176.58m-103.71m4.37bn626.00--17.52--24.75-2.06-2.063.504.850.5461.853.83282,068.70-32.07---36.52--54.73---58.73--6.49--0.1696--81.55---21.51------
DENTSPLY SIRONA Inc3.90bn-185.00m5.33bn15.00k--1.7432.501.37-0.8698-0.869818.6515.120.53562.946.18259,733.30-2.49-1.14-3.03-1.3252.2353.65-4.65-2.510.86923.650.4066--1.10-0.107186.11---4.549.86
TransMedics Group Inc358.76m3.00m5.50bn584.003,999.0328.95316.3815.340.04130.041310.615.700.49523.565.58614,313.400.4141-16.080.4403-17.9560.7165.370.8362-40.478.48--0.7278--158.5379.3630.92--225.12--
Merit Medical Systems Inc1.30bn117.43m5.80bn6.95k49.634.5227.234.452.012.0122.2422.040.61832.307.36187,231.105.582.456.132.7746.5444.509.023.914.6417.520.38460.009.247.3326.7015.86-11.16--
Stevanato Group SpA1.21bn136.81m5.83bn5.64k37.503.5625.734.800.51360.51364.545.420.5432.662.80215,440.706.12--8.34--30.06--11.27--1.1344.770.1926--10.34--1.95------
Inspire Medical Systems Inc705.71m6.01m6.35bn1.01k1,099.899.94644.818.990.19350.193523.7421.411.052.689.86698,026.700.8927-11.270.99-12.6084.8384.470.8518-13.578.35--0.00--53.1965.3252.87--148.37--
Masimo Corp2.02bn79.40m6.49bn3.80k82.594.7237.183.221.471.4737.3225.730.68311.945.77530,763.202.698.653.3210.3149.2857.303.9412.031.153.300.36350.000.604219.00-43.21-15.9631.06--
Glaukos Corp341.73m-158.61m7.02bn907.00--10.53--20.55-3.20-3.206.9112.130.36421.677.55376,764.10-16.91-8.73-18.20-9.3576.5374.77-46.41-28.694.67-56.930.16--11.2611.66-35.75--14.44--
Data as of Sep 20 2024. Currency figures normalised to DENTSPLY SIRONA Inc's reporting currency: US Dollar USD

Institutional shareholders

49.96%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202424.17m11.64%
Nuance Investments LLCas of 30 Jun 202410.88m5.24%
BlackRock Fund Advisorsas of 31 Mar 202410.76m5.18%
Fuller & Thaler Asset Management, Inc.as of 30 Jun 202410.27m4.95%
First Eagle Investment Management LLCas of 31 Mar 20249.79m4.71%
T. Rowe Price Investment Management, Inc.as of 31 Mar 20248.67m4.17%
SSgA Funds Management, Inc.as of 31 Mar 20248.13m3.92%
Cooke & Bieler LPas of 30 Jun 20247.51m3.62%
Janus Henderson Investors US LLCas of 31 Mar 20247.42m3.57%
Generation Investment Management LLPas of 31 Mar 20246.14m2.96%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.